Valuation Eurofins Scientific SE

Equities

Market Closed - Euronext Paris Other stock markets 16:55:00 13/03/2026 GMT			5-day change	1st Jan Change
61.48 ^EUR	-0.29%		-4.80%	-1.47%

03-05	Moody's Affirms Eurofins Scientific's Ratings, Outlook on Solid Operating Performance in FY25	MT
02-17	CIC Corporate Upgrades Eurofins Scientific to Buy Rating, Boosts PT	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	20,893	12,900	11,336	9,273	11,036	10,828	-	-
Change	-	-38.26%	-12.13%	-18.2%	19.02%	-1.89%	-	-
Enterprise Value (EV) ¹	23,132	15,739	14,041	12,269	11,036	14,273	13,807	13,497
Change	-	-31.96%	-10.79%	-12.62%	-10.05%	29.33%	-3.26%	-2.25%
P/E ratio	27.8x	22.2x	45.4x	26.9x	28x	20.1x	16x	13.5x
PBR	4.49x	2.7x	2.24x	1.73x	-	2.28x	2.06x	1.91x
PEG	-	-1x	-0.8x	0.7x	1.3x	0.5x	0.6x	0.7x
Capitalization / Revenue	3.11x	1.92x	1.74x	1.33x	1.51x	1.42x	1.32x	1.24x
EV / Revenue	3.44x	2.34x	2.16x	1.77x	1.51x	1.87x	1.68x	1.54x
EV / EBITDA	12.2x	10.4x	10.3x	7.91x	6.73x	8.16x	7.16x	6.39x
EV / EBIT	15.7x	15.2x	16.7x	12.1x	10.2x	12.6x	10.9x	9.5x
EV / FCF	22.8x	23.2x	29.6x	15.3x	-	20.6x	16.2x	14.7x
FCF Yield	4.39%	4.3%	3.38%	6.53%	-	4.85%	6.19%	6.81%
Dividend per Share ²	1	1	0.5	0.5	-	0.7543	0.8449	0.935
Rate of return	0.92%	1.49%	0.85%	1.01%	-	1.23%	1.37%	1.52%
EPS ²	3.91	3.02	1.3	1.83	2.23	3.058	3.843	4.558
Distribution rate	25.6%	33.1%	38.5%	27.3%	-	24.7%	22%	20.5%
Net sales ¹	6,718	6,712	6,515	6,951	7,296	7,642	8,197	8,745
EBITDA ¹	1,902	1,513	1,364	1,552	1,641	1,750	1,930	2,112
EBIT ¹	1,473	1,037	842	1,017	1,079	1,136	1,270	1,420
Net income ¹	783	606	310	406	475	572.7	728.3	854.5
Net Debt ¹	2,239	2,839	2,705	2,996	-	3,445	2,980	2,669
Reference price ²	108.80	67.06	58.98	49.31	62.40	61.48	61.48	61.48
Nbr of stocks (in thousands)	192,035	192,365	192,194	188,049	176,864	176,121	-	-
Announcement Date	22/02/22	01/03/23	27/02/24	30/01/25	29/01/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
EUROFINS SCIENTIFIC SE	20.1x	1.87x	8.16x	1.23%	12.39B
LONZA GROUP AG	33.07x	4.92x	16.5x	1.02%	42.78B
BEONE MEDICINES AG	51.27x	4.42x	29.75x	-.--%	31.5B
CELLTRION, INC.	54.26x	11.14x	30.96x	0.35%	29.99B
IQVIA HOLDINGS INC.	19.97x	2.36x	10.18x	-.--%	27.65B
REVOLUTION MEDICINES, INC.	-12.38x	320.84x	-10.44x	-.--%	18.8B
ASCENDIS PHARMA A/S	43.12x	8.22x	25.82x	-.--%	13.87B
MEDPACE HOLDINGS, INC.	26.34x	4.19x	19.06x	-.--%	12.78B
IONIS PHARMACEUTICALS, INC.	-17.61x	13.71x	-19.11x	-.--%	11.76B
Average	24.24x	41.30x	12.32x	0.29%	22.39B
Weighted average by Cap.	29.54x	35.39x	15.55x	0.34%